BGI Genomics
Chan Li is a marketing professional with extensive experience in the biotechnology sector. Currently serving as the Manager of Marketing at BGI-Shenzhen since August 2017, Chan Li oversees exhibition and conference progress, measures marketing campaign performance, and manages a diverse range of acquisition channels. Prior to this role, Chan Li worked as an Enrollment Analyst at ArchCare, where responsibilities included resolving enrollment issues, analyzing data, and enhancing training opportunities within the department. Chan Li's foundational education includes a Master's degree in Biomedical/Medical Engineering from New York University and a Bachelor's degree in Biotechnology from China Pharmaceutical University. Additionally, significant experience as a Teaching Assistant at New York University contributed to Chan Li's professional development.
This person is not in any offices
BGI Genomics
3 followers
BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. Today, BGI is actively participating in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a global network of collaborators. BGI Genomics is the world’s leading provider of genomic and proteomic services, now serving customers in more than 66 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic and proteomic services and solutions across a broad range of applications spanning basic and translational research, drug discovery, agriculture and health care. To provide these services, we operate a large network of service Laboratories in China, Hong Kong, the US and Europe. Our customers benefit from the highest level of sequencing experience in the world to support their research and drug discovery projects. Our service laboratories operate under strict internationally recognized quality systems, such as those from CAP and ISO. More recently, BGI developed and launched its own DNBseq™ sequencing technology, based on DNA Nanoball sequencing technology that was invented in our Complete Genomics research facility in Silicon Valley, California. Scientists around the world now rely on DNBseq NGS services for the highest quality data at the lowest cost.